In mice suffering from stress urinary incontinence (UI), periurethral injection of human amniotic fluid stem cells restored the urethral sphincter to apparently normal histology and function, according to a report in BMC Medicine.
These cells are easily collected and have very low immunogenicity, reducing risk of rejection, the researchers, led by James J. Yoo, MD, and Tae Gyun Kwon, MD, of the Kyungpook National University in Daegu, Korea, noted.
Although all stem cells disappeared from inside the mouse within 14 days, they were able to induce regeneration of the mouse’s own urethral sphincter muscle.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.